MENU

Supply Chain Intelligence about:

Aurobindo Pharma Ltd.

Company profile   India

See Aurobindo Pharma Ltd.'s products and customers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Reveal patterns in global trade

Top countries/regions supplied by Aurobindo Pharma Ltd.
Destination Country/Region
  • Brazil
    404 shipments (77.5%)
  • Paraguay
    103 shipments (19.8%)
  • Bolivia
    7 shipments (1.3%)
  • Ecuador
    3 shipments (0.6%)
  • Mexico
    2 shipments (0.4%)
  • Sri Lanka
    1 shipments (0.2%)
  • Pakistan
    1 shipments (0.2%)

Easy access to trade data

Cleaned and organized South American shipments

106 South American shipments available for Aurobindo Pharma Ltd.
Date Data Source Customer Details
2021-10-27 Ecuador Imports
DRESDENLAB ECUADOR S.A.
Shipment data shows what products a company is trading and more. Learn more

Explore trading relationships hidden in supply chain data

Contact information for Aurobindo Pharma Ltd.

 
Address
N/A
 
 

Sample Bill of Lading

561 shipment records available

Bill of Lading Number
CEC2021MAEU0466
Departure Date
2021-10-27
Arrival Date
2021-10-27
Consignee
Dresdenlab Ecuador S.A.
Consignee (Original Format)
DRESDENLAB ECUADOR S.A., GUAYAS
Consignee Number
0993058424001
Shipper
Aurobindo Pharma Ltd.
Shipper (Original Format)
AUROBINDO PHARMA LTD
Carrier
SUDU - Hamburg Sued
Notify Party
DRESDENLAB ECUADOR S.A.
Shipment Origin
India
Shipment Origin (Original Format)
INDIA
Shipment Destination
GUAYAQUIL
Port of Origin
JAWAHARLAL NEHRU (NHAVA SHEVA)
Port of Unlading
Guayaquil (EC)
Port of Lading
Hong Kong (HK)
Vessel
MAERSK SAVANNAH
Vessel (Original Format)
DK
Volume (TEU)
0.0
Item Quantity
2.0
Item Unit
PALETA
Gross Weight (kg)
722.01
Container Type
LCL
Container Numbers
MNBU0649349
Container Number 20
0.0
Container Number 40
0.0
Agent Name
HAMBURG SÃœD ECUADOR S.A.

Recent Panjiva Research about Aurobindo Pharma Ltd.

20170112-pharma-trump

Are Pharma Imports Reddy for Trump?

The latest industry to face President-elect Trump’s attention is pharmaceutical manufacturing, where a commitment has been made to cut costs. While it is not clear how this will be achieved, the U.S. has made significant use of imported generic drugs once branded versions’ patents end. Panjiva... Read more →

20161122-anticonvulsant-total

Lamotrigine Leads AC Drug Import Growth, GSK Doesn’t Gain

U.S. imports of anticonvulsant drugs (AC), used for epilepsy, migraine and bipolar treatments, climbed 42% in October, the 18th straight increase. This was led by lamotrigine which jumped 150%. Generic drugmakers including Aurobindo Pharma, Cipla and Cadila have taken the lion’s share of the g... Read more →